World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
18808
World Ranking
2403
National Ranking
1153

Smita Nair publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Smita Nair sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Smita Nair D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Smita Nair sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Smita Nair is affiliated with Duke University in the United States and has a substantial body of research primarily within the field of Medicine, with a focus on Oncology, Immunology, and Molecular Biology. Their work encompasses areas such as Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, and CAR-T cell therapy research.

The main subfields of Smita Nair's study include:

  • Oncology
  • Immunology
  • Molecular Biology
  • Surgery
  • Genetics

Key topics covered by their research involve:

  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Nanoplatforms for cancer theranostics
  • RNA Interference and Gene Delivery
  • Cutaneous Melanoma Detection and Management
  • COVID-19 Clinical Research Studies

Smita Nair has published extensively in several scientific venues, with frequent publications appearing in:

  • Neuro-Oncology
  • Advanced Science
  • Journal of Controlled Release
  • Nanophotonics
  • Frontiers in Bioscience-Landmark

Recent papers authored by Smita Nair include:

  • "Polyethylene Glycol-Like Brush Polymer Conjugate of a Protein Drug Does Not Induce an Antipolymer Immune Response and Has Enhanced Pharmacokinetics than Its Polyethylene Glycol Counterpart" (2022), Advanced Science
  • "Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot" (2022), Journal of Controlled Release
  • "Plasmonic gold nanostars for synergistic photoimmunotherapy to treat cancer" (2021), Nanophotonics
  • "Oncolytic viruses in melanoma" (2022), Frontiers in Bioscience-Landmark
  • "Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma" (2020), Annals of Surgical Oncology

Frequent co-authors collaborating with Smita Nair are:

  • John H. Sampson
  • Georgia M. Beasley
  • David M. Ashley
  • Kristen A. Batich
  • Lyra B. Olson

Best Publications

  • Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

    David Boczkowski;Smita K. Nair;David Snyder;Eli Gilboa

  • Recurrent glioblastoma treated with recombinant poliovirus

    Annick Desjardins;Matthias Gromeier;James E. Herndon;Nike Beaubier

  • Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

    David M. Ashley;Brenda Faiola;Smita Nair;Laura P. Hale

  • Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

    Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang

  • Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

    S K Nair;D Boczkowski;M Morse;R I Cumming

  • Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

    Smita K. Nair;Axel Heiser;David Boczkowski;Anish Majumdar

  • Induction of Tumor Immunity and Cytotoxic T Lymphocyte Responses Using Dendritic Cells Transfected with Messenger RNA Amplified from Tumor Cells

    D Boczkowski;S K Nair;J H Nam;H K Lyerly

  • A Phase I Study of Active Immunotherapy with Carcinoembryonic Antigen Peptide (CAP-1)-pulsed, Autologous Human Cultured Dendritic Cells in Patients with Metastatic Malignancies Expressing Carcinoembryonic Antigen

    M. A. Morse;Yuping Deng;D. Coleman;S. Hull

  • Immunotherapy of cancer with dendritic-cell-based vaccines

    E Gilboa;S K Nair;H K Lyerly

  • Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

    Axel Heiser;Margaret A. Maurice;Donna R. Yancey;Ning Z. Wu

  • From the RNA world to the clinic.

    Bruce A. Sullenger;Smita Nair

  • EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

    John H. Sampson;Bryan D. Choi;Luis Sanchez-Perez;Carter M. Suryadevara

  • Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts.

    Smita K. Nair;David Snyder;Barry T. Rouse;Eli Gilboa

  • Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro

    S Nair;F Zhou;R Reddy;L Huang

  • Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

    Kristen A. Batich;Elizabeth A. Reap;Gary E. Archer;Luis Sanchez-Perez

  • Human Dendritic Cells Transfected with RNA Encoding Prostate-Specific Antigen Stimulate Prostate-Specific CTL Responses In Vitro

    Axel Heiser;Philipp Dahm;Donna R. Yancey;Margaret A. Maurice

  • Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization

    Fei Zhao;Christine Xiao;Kathy S. Evans;Tbalamayooran Theivanthiran

  • Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.

    Smita K. Nair;Michael Morse;David Boczkowski;R. Ian Cumming

  • RNA-Based Vaccines in Cancer Immunotherapy.

    Megan A. McNamara;Smita K. Nair;Eda K. Holl

  • Multivalent RNA Aptamers That Inhibit CTLA-4 and Enhance Tumor Immunity

    Sandra Santulli-Marotto;Smita K. Nair;Chris Rusconi;Bruce Sullenger

  • Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA.

    Smita K. Nair;Shelley Hull;Doris Coleman;Eli Gilboa

  • Synergy between tumor immunotherapy and antiangiogenic therapy

    Smita Nair;David Boczkowski;Benjamin Moeller;Mark Dewhirst

Frequent Co-Authors

Eli Gilboa
Eli Gilboa University of Miami
Darell D. Bigner
Darell D. Bigner Duke University
John H. Sampson
John H. Sampson Duke University
Bruce A. Sullenger
Bruce A. Sullenger Duke University
Barry T. Rouse
Barry T. Rouse University of Tennessee at Knoxville
James E. Herndon
James E. Herndon Duke University
Michael A. Morse
Michael A. Morse Duke University
Allan H. Friedman
Allan H. Friedman Duke University
Gary E. Archer
Gary E. Archer Duke University
Henry S. Friedman
Henry S. Friedman Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related health-focused online degrees can provide diverse career opportunities. Many students start with practical nursing credentials, and finding which LPN programs are easiest to get into can be a great first step. Licensed Practical Nurses gain foundational skills that complement immunology knowledge in patient care settings.

Advancing further, nursing professionals often pursue advanced practice degrees. For example, discovering the easiest online nurse practitioner programs allows learners to balance education with their career. These programs often integrate clinical practice, crucial for applying immunological concepts in medical treatment.

Specializing in mental health, the best online psychiatric mental health nurse practitioner programs offer strong clinical placement opportunities. This specialty illustrates how immunology intersects with brain and behavioral health, opening pathways to psychiatric care careers.

For those budgeting their education, identifying the cheapest PMHNP programs online can make essential specialized training accessible. Affordable options enable more students to enter advanced roles while continuing to broaden their expertise in immunological and psychiatric nursing.

Best Scientists Citing Smita Nair

Trending Scientists

Recently Published Articles